| 2.47 -0.015 (-0.6%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.22 |
1-year : | 3.6 |
| Resists | First : | 2.75 |
Second : | 3.08 |
| Pivot price | 2.55  |
|||
| Supports | First : | 2.22 |
Second : | 1.84 |
| MAs | MA(5) : | 2.54 |
MA(20) : | 2.53 |
| MA(100) : | 2.31 |
MA(250) : | 2.35 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 42.9 |
D(3) : | 58.3 |
| RSI | RSI(14): 47.8 |
|||
| 52-week | High : | 3.11 | Low : | 1.97 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ KRMD ] has closed above bottom band by 19.3%. Bollinger Bands are 34.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.52 - 2.54 | 2.54 - 2.55 |
| Low: | 2.4 - 2.43 | 2.43 - 2.45 |
| Close: | 2.44 - 2.47 | 2.47 - 2.49 |
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Fri, 26 Jul 2024
KORU Medical Systems (NASDAQ:KRMD) Receives New Coverage from Analysts at B. Riley - Defense World
Thu, 25 Jul 2024
KORU Medical Systems (NASDAQ:KRMD) Receives New Coverage from Analysts at B. Riley - MarketBeat
Thu, 25 Jul 2024
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference - StockTitan
Thu, 25 Jul 2024
KORU Medical Systems Promotes Christopher Pazdan to Chief Operating Officer - citybiz
Thu, 25 Jul 2024
KORU Medical Systems, Inc. (NASDAQ:KRMD) is definitely on the radar of institutional investors who own 33% of the company - Yahoo Finance
Thu, 25 Jul 2024
KORU Medical Systems announces key executive changes - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 46 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 6.4 (%) |
| Held by Institutions | 64.1 (%) |
| Shares Short | 1,260 (K) |
| Shares Short P.Month | 1,280 (K) |
| EPS | -0.29 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.41 |
| Profit Margin | -45.3 % |
| Operating Margin | -24 % |
| Return on Assets (ttm) | -17.5 % |
| Return on Equity (ttm) | -54.3 % |
| Qtrly Rev. Growth | 10.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.64 |
| EBITDA (p.s.) | -0.19 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -8.52 |
| PEG Ratio | 0 |
| Price to Book value | 5.88 |
| Price to Sales | 3.85 |
| Price to Cash Flow | -195.32 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|